Document Classification

Section Type: RESULTS

Text: Comparing ranibizumab 0. 5 mg versus sham or PTD treatment, respectively : 39. 9 % versus 29. 1 % and 10. 9 % versus 5. 1 % had maximum preinjection IOPs of 21 mmHg or more or 25 mmHg or more, respectively ; 44. 1 % versus 29. 9 % and 24. 2 % versus 13. 6 % had IOP increases from baseline of 6 mmHg or more or 8 mmHg or more, respectively ; 26. 1 % versus 13. 6 % and 16. 8 % versus 9. 0 % had 1 or more IOP increase from baseline of 6 mmHg or more or 8 mmHg or more, respectively, with a concurrent IOP of 21 mmHg or more ; 9. 6 % versus 3. 7 % and 7. 5 % versus 2. 4 % had 1 or more IOP increase from baseline of 6 mmHg or more or 8 mmHg or more, respectively, with a concurrent IOP of 25 mmHg or more.